Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 38471013.
- Also identified by DOI 10.1164/rccm.202308-1384OC and PMC identifier 11506912.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>Rationale:</b> Body mass index (BMI) is associated with chronic obstructive pulmonary disease (COPD) mortality, but the underlying mechanisms are unclear. The effect of genetic variants aggregated into a polygenic score may elucidate the causal mechanisms and predict risk. <b>Objectives:</b> To examine the associations of genetically predicted BMI with all-cause and cause-specific mortality in COPD. <b>Methods:</b> We developed a polygenic score (PGS) for BMI (PGS<sub>BMI</sub>) and tested for associations of the PGS<sub>BMI</sub> with all-cause, respiratory, and cardiovascular mortality in participants with COPD from the COPDGene (Genetic Epidemiology of COPD), ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points), and Framingham Heart studies. We calculated the difference between measured BMI and PGS-predicted BMI (BMI<sub>diff</sub>) and categorized participants into groups of discordantly low (BMI<sub>diff</sub> <20th percentile), concordant (BMI<sub>diff</sub> between the 20th and 80th percentiles), and discordantly high (BMI<sub>diff</sub> >80th percentile) BMI. We applied Cox models, examined potential nonlinear associations of the PGS<sub>BMI</sub> and BMI<sub>diff</sub> with mortality, and summarized results with meta-analysis. <b>Measurements and Main Results:</b> We observed significant nonlinear associations of measured BMI and BMI<sub>diff</sub>, but not PGS<sub>BMI</sub>, with all-cause mortality. In meta-analyses, a one-standard deviation increase in the PGS<sub>BMI</sub> was associated with an increased hazard for cardiovascular mortality (hazard ratio [HR], 1.29; 95% confidence interval [CI], 1.12-1.49), but not for respiratory or all-cause mortality. Compared with participants with concordant measured and genetically predicted BMI, those with discordantly low BMI had higher risks for all-cause mortality (HR, 1.57; 95% CI, 1.41-1.74) and respiratory death (HR, 2.01; 95% CI, 1.61-2.51). <b>Conclusions:</b> In people with COPD, a higher genetically predicted BMI is associated with higher cardiovascular mortality but not respiratory mortality. Individuals with a discordantly low BMI have higher all-cause and respiratory mortality rates than those with a concordant BMI.
Medical subject headings
- Pulmonary Disease, Chronic Obstructive
- Body Mass Index